Cargando…

N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis

Background: Emerging evidence suggests the clinical utility of N terminal pro B type natriuretic peptide (NT-proBNP) in multiple cardiac and pulmonary abnormalities both in adult and pediatric populations. To date, however, there is no consensus regarding its efficacy for the prediction and severity...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodolaki, Kalliopi, Pergialiotis, Vasilios, Sapantzoglou, Ioakeim, Theodora, Marianna, Antsaklis, Panagiotis, Pappa, Kalliopi, Daskalakis, Georgios, Papapanagiotou, Aggeliki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532602/
https://www.ncbi.nlm.nih.gov/pubmed/37763055
http://dx.doi.org/10.3390/jpm13091287
_version_ 1785111999433146368
author Rodolaki, Kalliopi
Pergialiotis, Vasilios
Sapantzoglou, Ioakeim
Theodora, Marianna
Antsaklis, Panagiotis
Pappa, Kalliopi
Daskalakis, Georgios
Papapanagiotou, Aggeliki
author_facet Rodolaki, Kalliopi
Pergialiotis, Vasilios
Sapantzoglou, Ioakeim
Theodora, Marianna
Antsaklis, Panagiotis
Pappa, Kalliopi
Daskalakis, Georgios
Papapanagiotou, Aggeliki
author_sort Rodolaki, Kalliopi
collection PubMed
description Background: Emerging evidence suggests the clinical utility of N terminal pro B type natriuretic peptide (NT-proBNP) in multiple cardiac and pulmonary abnormalities both in adult and pediatric populations. To date, however, there is no consensus regarding its efficacy for the prediction and severity of bronchopulmonary dysplasia in premature neonates. The objective of the present meta-analysis was to determine differences in NT-proBNP among neonates that develop BPD or die from BPD and to evaluate if there is relative information on the diagnostic accuracy of the method. Methods: We conducted a systematic search according to the PRISMA guidelines and looked into Medline (1966–2023), Scopus (2004–2023), Clinicaltrials.gov (2008–2023), EMBASE (1980–2023), Cochrane Central Register of Controlled Trials CENTRAL (1999–2022) and Google Scholar (2004–2023) together with the reference lists from included studies. The potential risk of bias encountered in our study was evaluated using the QUADAS -2 tool. Finally, a total of 9 studies met the eligibility criteria, comprising 1319 newborns, from which 397 developed BPD and 922 were unaffected controls. Results: The results retrieved from our meta-analysis showed that newborns suffering from BPD had notably elevated NT-proBNP levels after birth when compared with healthy neonates (SMD 2.57, 95% CI 0.41, 4.72). The summary effect of the AUC meta-analysis showed that NT-proBNP was very accurate in detecting neonates at risk of developing severe BPD or dying from the disease (AUC −0.16, 95% CI −0.23, −0.08). No studies reported data relevant to the sensitivity and/or specificity of the method in diagnosing BPD. Conclusion: Serum NT-proBNP levels represent a potential future biomarker with great diagnostic validity for the prediction of BPD complicating preterm deliveries. The limited amount of studies included and the significant variations in cutoff values and timing of measurement still restrict the application of NT-proBNP as an established clinical biomarker for BPD. The design of larger prospective studies will provide a more representative number of participants and will address the discrepancies in existing literature.
format Online
Article
Text
id pubmed-10532602
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105326022023-09-28 N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis Rodolaki, Kalliopi Pergialiotis, Vasilios Sapantzoglou, Ioakeim Theodora, Marianna Antsaklis, Panagiotis Pappa, Kalliopi Daskalakis, Georgios Papapanagiotou, Aggeliki J Pers Med Systematic Review Background: Emerging evidence suggests the clinical utility of N terminal pro B type natriuretic peptide (NT-proBNP) in multiple cardiac and pulmonary abnormalities both in adult and pediatric populations. To date, however, there is no consensus regarding its efficacy for the prediction and severity of bronchopulmonary dysplasia in premature neonates. The objective of the present meta-analysis was to determine differences in NT-proBNP among neonates that develop BPD or die from BPD and to evaluate if there is relative information on the diagnostic accuracy of the method. Methods: We conducted a systematic search according to the PRISMA guidelines and looked into Medline (1966–2023), Scopus (2004–2023), Clinicaltrials.gov (2008–2023), EMBASE (1980–2023), Cochrane Central Register of Controlled Trials CENTRAL (1999–2022) and Google Scholar (2004–2023) together with the reference lists from included studies. The potential risk of bias encountered in our study was evaluated using the QUADAS -2 tool. Finally, a total of 9 studies met the eligibility criteria, comprising 1319 newborns, from which 397 developed BPD and 922 were unaffected controls. Results: The results retrieved from our meta-analysis showed that newborns suffering from BPD had notably elevated NT-proBNP levels after birth when compared with healthy neonates (SMD 2.57, 95% CI 0.41, 4.72). The summary effect of the AUC meta-analysis showed that NT-proBNP was very accurate in detecting neonates at risk of developing severe BPD or dying from the disease (AUC −0.16, 95% CI −0.23, −0.08). No studies reported data relevant to the sensitivity and/or specificity of the method in diagnosing BPD. Conclusion: Serum NT-proBNP levels represent a potential future biomarker with great diagnostic validity for the prediction of BPD complicating preterm deliveries. The limited amount of studies included and the significant variations in cutoff values and timing of measurement still restrict the application of NT-proBNP as an established clinical biomarker for BPD. The design of larger prospective studies will provide a more representative number of participants and will address the discrepancies in existing literature. MDPI 2023-08-23 /pmc/articles/PMC10532602/ /pubmed/37763055 http://dx.doi.org/10.3390/jpm13091287 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Rodolaki, Kalliopi
Pergialiotis, Vasilios
Sapantzoglou, Ioakeim
Theodora, Marianna
Antsaklis, Panagiotis
Pappa, Kalliopi
Daskalakis, Georgios
Papapanagiotou, Aggeliki
N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis
title N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis
title_full N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis
title_fullStr N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis
title_full_unstemmed N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis
title_short N-Terminal Pro-B Type Natriuretic Peptide as a Predictive Biomarker of Bronchopulmonary Dysplasia or Death Due to Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Meta-Analysis
title_sort n-terminal pro-b type natriuretic peptide as a predictive biomarker of bronchopulmonary dysplasia or death due to bronchopulmonary dysplasia in preterm neonates: a systematic review and meta-analysis
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532602/
https://www.ncbi.nlm.nih.gov/pubmed/37763055
http://dx.doi.org/10.3390/jpm13091287
work_keys_str_mv AT rodolakikalliopi nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis
AT pergialiotisvasilios nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis
AT sapantzoglouioakeim nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis
AT theodoramarianna nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis
AT antsaklispanagiotis nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis
AT pappakalliopi nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis
AT daskalakisgeorgios nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis
AT papapanagiotouaggeliki nterminalprobtypenatriureticpeptideasapredictivebiomarkerofbronchopulmonarydysplasiaordeathduetobronchopulmonarydysplasiainpretermneonatesasystematicreviewandmetaanalysis